Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

ARMO BioSciences, Inc. - Common Stock (NQ: ARMO )

N/A UNCHANGED
Last Price Updated: Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about ARMO BioSciences, Inc. - Common Stock

Loading Dock System Market Research & Clinical Advancements by 2028 | Assa Abloy, Loading Systems
Tags Loading Dock System market in Key Countries Loading Dock System BUTT
From X herald
The Week Ahead: FANG Earnings Continue, Fox Vote On Disney Deal, More IPOs
Below is a list of notable corporate events for the week beginning July 23. Note, this list is not comprehensive and all dates are ... 
Tags FCAU NTNX GRUB
From Benzinga
Better Buy: Johnson & Johnson vs. Eli Lilly
Which of these big pharma stocks has a better chance to outperform for your portfolio. 
Tags Market News ARMO LLY
From Motley Fool
The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines
A few FDA approvals and the impending 2018 American Society of Clinical Oncology annual meeting gave some impetus to the biotech space ... 
Tags Market News INFN ZLAB
From Benzinga
UPDATE 1-Lilly to buy cancer drug developer AurKa Pharma
May 14 (Reuters) - Eli Lilly and Co will buy AurKa Pharma Inc in a deal potentially worth up to $575 million, the U.S. drugmaker said on Monday, seeking access to the privately-held firm's experimental... 
Tags companyNews
From Reuters: Company News
Week In Review: $3.4 Billion Week For China Life Science Deals
Armo Biosciences, a Bay Area immuno-oncology company, agreed to be acquired by Eli Lilly. Lilly offered to pay $50 per share for Armo, a three-fold increase from the IPO price and a 67% jump from its... 
Tags Stocks / Equities Pharma/Biotech
From Blogs - TalkMarkets
3 Biotech Stocks That Soared This Week: Are They Buys?
Can the momentum keep going for these sizzling-hot biotech stocks? 
Tags ARWR ARMO Market News
From Motley Fool
Week in Review: $3.4 Billion Week for China Life Science Deals
Deals and Financings   Armo Biosciences, a Bay Area immuno-oncology company backed by China investors, will be acquired by Eli Lilly in a $1.6 billion transaction; Luye Pharma of Yantai will pay $538... 
From ChinaBio® Today
Benzinga's Top Upgrades, Downgrades For May 11, 2018
Top Upgrades JP Morgan upgraded Verizon Communications Inc. (NYSE: VZ) from Neutral to Overweight. Verizon shares rose 0.97 ... 
Tags BIDU KSS Analyst Ratings
From Benzinga
55 Biggest Movers From Yesterday
Gainers ARMO BioSciences, Inc. (NASDAQ: ARMO) shares gained 67 percent to close at $49.80 after Eli Lilly and Company (NYSE: ... 
Tags VTVT CECE PBYI
From Benzinga
Biotech Stocks Underperform Market: CELG, EXEL, PBYI, XBI
Biotechs underperformed despite a good opening with the XBI trying to break through the SMA 50 level but fell back around mid-day. 
Tags Pharma/Biotech Stocks / Equities Healthcare
From Blogs - TalkMarkets
Markets soar on mild inflation
Mild inflation data sent the markets soaring to a sharply higher close with the Dow leaping 196 points to 24,739. Nasdaq climbed 65 points to 7404. 
Tags Market News
From MarketMinute.com Market Updates
Eli Lilly to buy ARMO BioSciences
ARMO BioSciences Inc. (Nasdaq: ARMO) will be acquired by Eli Lilly (NYSE: LLY) for a premium of approximately $1.6 billion in cash. Shares of ARMO BioSciences rocketed $19.98 to close at $49.80 while... 
From MarketMinute.com Stock News
Why Spotify Technology, CenturyLink, and ARMO BioSciences Jumped Today
Find out why these stocks led the market higher. 
Tags Market News ARMO LLY
From Motley Fool
Mid-Afternoon Market Update: Prestige Brands Gains On Earnings Beat; MDC Partners Shares Slide
Toward the end of trading Thursday, the Dow traded up 0.74 percent to 24,723.63 while the NASDAQ climbed 0.75 percent to 7,394.55. The ... 
Tags Market News PBH CEL
From Benzinga
ARMO Biosciences Soars 67% on $1.6 Billion Buyout
One of the largest pharma companies in the world moved to boost its cancer immunotherapy pipeline. 
Tags Market News LLY ARMO
From Motley Fool
40 Stocks Moving In Thursday's Mid-Day Session
Gainers Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and ... 
Tags PTGX Trading Ideas WMGI
From Benzinga
Mid-Day Market Update: Dow Rises 150 Points; Hudson Technologies Shares Plunge
Midway through trading Thursday, the Dow traded up 0.65 percent to 24,702.16 while the NASDAQ climbed 0.63 percent to 7,386.41. The ... 
Tags LLY Eurozone Commodities
From Benzinga
UPDATE 3-Lilly to buy Armo Biosciences for $1.6 bln to bolster cancer pipeline
* Armo's lead drug has presented data for several cancer types 
Tags companyNews
From Reuters: Company News
Armo, Backed by China Investors, To Be Acquired by Lilly for $1.6 Billion
Armo Biosciences, a Bay Area immuno-oncology company, agreed to be acquired by Eli Lilly in a $1.6 billion transaction. Last year, Armo raised $67 million in a 2017 Series C-1 funding from China... 
From ChinaBio® Today
Mid-Morning Market Update: Markets Open Higher; Magna Tops Q1 Views
Following the market opening Thursday, the Dow traded up 0.35 percent to 24,629.29 while the NASDAQ climbed 0.40 percent to 7,369.50. ... 
Tags LLY Commodities PTNR
From Benzinga
UPDATE 2-Lilly to buy Armo Biosciences for $1.6 bln to bolster cancer pipeline
May 10 (Reuters) - Eli Lilly and Co said on Thursday it would buy Armo BioSciences Inc for about $1.6 billion to expand its portfolio of drugs that seeks to help body's immune system fight cancer as... 
Tags companyNews
From Reuters: Company News
Benzinga's Daily Biotech Pulse: ARMO Skyrockets On Eli Lilly Deal, Akcea Meets FDA Panel, vTv Alzheimer's Trial Results
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling the Peaks (Stocks hitting 52-week ... 
Tags BDSI CATB Market News
From Benzinga
Deals of the day-Mergers and acquisitions
May 10 (Reuters) - The following bids, mergers, acquisitions and disposals were reported by 1330 GMT on Thursday: 
Tags companyNews
From Reuters: Company News
Eli Lilly Swipes New IPO Armo Biosciences In $1.6 Billion Bid
Eli Lilly put up a $1.6 billion bid to buy Armo Biosciences early Thursday in a plan to bolster its immuno-oncology assets. 
From Investor's Business Daily
32 Stocks Moving In Thursday's Pre-Market Session
Gainers ARMO BioSciences, Inc. (NASDAQ: ARMO) shares rose 67.5 percent to $49.96 in pre-market trading after Eli Lilly and ... 
Tags CLNE INFN Market News
From Benzinga
UPDATE 1-Lilly to buy Armo Biosciences for $1.6 bln to bolster cancer pipeline
May 10 (Reuters) - Drugmaker Eli Lilly and Co said on Thursday it would buy Armo BioSciences Inc for about $1.6 billion to bolster its portfolio of cancer drugs, merely four months after the smaller... 
Tags companyNews
From Reuters: Company News
BRIEF-Lilly Announces Agreement To Acquire Armo Biosciences
* ARMO BIOSCIENCES INC - LILLY WILL COMMENCE TENDER OFFER TO ACQUIRE ALL SHARES OF ARMO FOR PURCHASE PRICE OF $50 PER SHARE IN CASH 
Tags companyNews
From Reuters: Company News
Lilly to buy Armo Biosciences for $1.6 bln
May 10 (Reuters) - Drugmaker Eli Lilly and Co said on Thursday it would buy Armo BioSciences Inc for about $1.6 billion to get access to the drug developer's experimental cancer treatment. 
Tags companyNews
From Reuters: Company News
38 Biggest Movers From Yesterday
Gainers China Advanced Construction Materials Group, Inc. (NASDAQ: CADC) shares rose 40.43 percent to close at $3.30 on ... 
Tags EYEG NVLN ALOG
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.